SNY News Alert Sanofi-Aventis Sa (SNY) 46.35 12/25/2014 06:1

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Sanofi-Aventis Sa (SNY) 46.35 $SNY

Anika Therapeutics: U.S. Approval To Drive Profit And Valuation
KEMS Research - Seeking Alpha - Tue Dec 23, 5:45AM CST
Description Anika Therapeutics (NASDAQ: ANIK ) is a small cap, biotech company focused on commercializing hyaluronic acid (HA) based therapeutic solutions. HA is naturally present in human bodies and is found primarily in the skin,...
ANIK: 38.26 (+0.73), SNY: 46.35 (+0.50)

Alnylam Pharmaceuticals Continues To Post Encouraging Results
Stephen Simpson, CFA - at Seeking Alpha - Mon Dec 22, 11:15AM CST

ALNY: 93.52 (+0.97), MDCO: 27.06 (+0.21), ALXN: 181.96 (+3.09), SNY: 46.35 (+0.50)

Overvalued Bonds Or Would You Buy Stocks With A PE Of 100?
Seeking Early Retirement - at Seeking Alpha - Mon Dec 22, 8:31AM CST

BTI: 110.32 (+1.08), IEF: 105.25 (-0.08), COP: 70.13 (-0.92), MO: 50.36 (-0.17), GSK: 42.85 (+0.11), VOD: 34.65 (-0.05), PM: 83.15 (-0.15), T: 33.96 (-0.07), SPY: 207.77 (+0.02), RDS.A: 68.42 (-0.31), DIA: 180.03 (unch), BP: 38.95 (-0.17), SNY: 46.35 (+0.50), CVX: 113.47 (-0.48), VZ: 47.67 (unch)

Lieff Cabraser Announces Class Action Litigation Against Sanofi - SNY
Business Wire - Mon Dec 22, 8:00AM CST
The law firm of Lieff Cabraser Heimann & Bernstein, LLP announces that class action litigation has been brought on behalf of those who purchased or otherwise acquired the securities of Sanofi ("Sanofi" or the "Company" (NYSE: SNY) between February 7, 2013 and December 3, 2014, inclusive (the "Class Period" .
SNY: 46.35 (+0.50)

Buying These 3 Stocks Is Like Making a Bet in a Burning House
George Budwell, The Motley Fool - Motley Fool - Mon Dec 22, 7:54AM CST
Source: Flickr user Mark Esau Bargain hunters are often attracted to beaten-down biotech stocks because they sometimes rebound in astonishing fashion. That said, it can be extremely difficult to separate the wheat from the chaff when mulling over...
OREX: 5.98 (+0.01), AZN: 70.44 (+0.26), VVUS: 2.99 (-0.02), AMGN: 160.67 (+3.15), AEGR: 21.59 (-0.27), SNY: 46.35 (+0.50), MNKD: 5.68 (+0.18)

EQUITY ALERT: Rosen Law Firm Reminds Sanofi Investors of Important Class Action Deadline - SNY
GlobeNewswire - Sun Dec 21, 7:25PM CST
The Rosen Law Firm, a global investor-rights firm, reminds purchasers of Sanofi securities (NYSE:SNY) during the period from February 7, 2013 through December 3, 2014, of the important February 2, 2015 lead plaintiff deadline in the class action.
SNY: 46.35 (+0.50)

Why Is George Soros Buying This Beaten Down Biotech Stock?
George Budwell, The Motley Fool - Motley Fool - Sun Dec 21, 10:04AM CST
Source: Wikimedia Commons/ Niccolò Caranti   The controversial billionaire and hedge  fund guru George Soros is undoubtedly one of the best investors on the planet today. At age 83, he is estimated to be the seventh-richest American, with a net...
PFE: 31.42 (-0.03), AZN: 70.44 (+0.26), SRPT: 13.88 (+0.47), AMGN: 160.67 (+3.15), AEGR: 21.59 (-0.27), SNY: 46.35 (+0.50)

SANOFI SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Sanofi -- SNY
GlobeNewswire - Sat Dec 20, 9:00PM CST
Kahn Swick & Foti, LLC ("KSF" and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until February 2, 2015 to file lead plaintiff applications in a securities class action lawsuit against Sanofi (NYSE:SNY) if they purchased the Company's securities between February 7, 2013 and December 3, 2014, inclusive (the "Class Period" . This action is pending in the United States District Court for the Southern District of New York.
SNY: 46.35 (+0.50)

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Sanofi of Class Action Lawsuit and Upcoming Deadline -- SNY
GlobeNewswire - Fri Dec 19, 4:12PM CST
Pomerantz LLP has filed a class action lawsuit against Sanofi ("Sanofi" or the "Company" (NYSE:SNY) and certain of its officers. The class action, filed in United States District Court, Southern District of New York, and docketed under 14-cv-9624, is on behalf of a class consisting of all persons or entities who purchased Sanofi securities between February 7, 2013 and December 3, 2014, inclusive (the "Class Period" . This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934 (the "Exchange Act" .
SNY: 46.35 (+0.50)

Doug Loe: Canada Has Earned Its Spot In The Biotech All-Star Team Photo
Life Sciences Report - Seeking Alpha - Fri Dec 19, 9:53AM CST
Biotech investors in the United States who overlook investment opportunities across the borders are missing out on huge opportunities, says Douglas Loe, healthcare equity analyst with Euro Pacific Canada. In this interview with The Life Sciences...
BIIB: 340.89 (+5.13), VRX: 140.33 (-0.22), QLTI: 3.72 (+0.08), CTRX: 51.83 (+0.14), BCRX: 11.83 (+0.76), ACT: 254.20 (-1.68), MDT: 74.08 (+0.31), TKMR: 13.97 (+0.14), NEPT: 1.88 (+0.03), BSX: 13.13 (+0.07), AGN: 210.12 (+0.95), CMRX: 36.80 (+0.70), ALNY: 93.52 (+0.97), SRPT: 13.88 (+0.47), SHPG: 209.29 (+0.07), NLNK: 39.08 (+1.36), SNY: 46.35 (+0.50), MSLI: 1.67 (+0.02), NVCN: 6.60 (unch), CRME: 8.56 (+0.06), EBS: 27.64 (+1.28), GSK: 42.85 (+0.11), CELG: 109.60 (+3.48), GILD: 91.29 (+1.84), MRK: 57.46 (+0.25), NVDQ: 16.90 (+0.55), NVS: 93.91 (+0.66)

The Best Healthcare Stocks of 2014: Which Is Our Favorite for 2015?
Todd Campbell, The Motley Fool - Motley Fool - Fri Dec 19, 6:44AM CST
From Medicaid expansion to cancer drugs to minimally invasive treatment for heart disease, Industry Focus looks at the 10 top performers among large-cap healthcare stocks in 2014. There were some surprises on the list this year, with strong showings...
AGN: 210.12 (+0.95), MDVN: 99.23 (+1.23), CNC: 105.96 (+1.03), JNJ: 104.59 (+0.31), VRX: 140.33 (-0.22), ACT: 254.20 (-1.68), EW: 130.75 (+1.17), SNY: 46.35 (+0.50), REGN: 400.12 (+6.07)

5 Big Stocks to Trade After the Fed's Rate News: Microsoft, Goldman and More
at The Street - Thu Dec 18, 11:08AM CST
Here's a closer technical look at five big stocks to trade for gains.
BRO: 32.76 (-0.02), GS: 195.89 (+0.39), UBS: 17.61 (+0.11), SNY: 46.35 (+0.50), MSFT: 48.14 (-0.31)

Cramer's Lightning Round - Why Did They Fire The Nice Man At Sanofi? (12/17/14)
SA Editor Miriam Metzinger - Seeking Alpha - Thu Dec 18, 5:08AM CST
Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Wednesday December 17. Bullish Calls: General Electric (NYSE: GE ): "It is a good stock with a good yield." Bristol Myers (NYSE: BMY ): ...
NLY: 11.21 (-0.05), BCRX: 11.83 (+0.76), GE: 25.83 (-0.05), DDD: 30.54 (-0.64), BMY: 59.15 (-0.01), SNY: 46.35 (+0.50)

'Mad Money' Lightning Round: GE Is a Good Stock With Good Yield
at The Street - Thu Dec 18, 5:00AM CST
Cramer is skittish on Sanofi, can't recommend C&J Energy Services and doesn't want you in Annaly Capital.
NLY: 11.21 (-0.05), GE: 25.83 (-0.05), CJES: 13.39 (-0.29), BCRX: 11.83 (+0.76), DDD: 30.54 (-0.64), AGIO: 109.67 (+2.45), ABBV: 66.21 (+1.86), BMY: 59.15 (-0.01), SNY: 46.35 (+0.50), HPQ: 40.54 (+0.18), REGN: 400.12 (+6.07), CELG: 109.60 (+3.48)

Jim Cramer's 'Mad Money' Recap: Why This Market Is All About Velocity
at The Street - Wed Dec 17, 7:16PM CST
A day's rest from the selling in oil will allow investors, analysts and oil companies themselves some time to assess their situations, Cramer says.
MNST: 112.56 (+0.52), BCRX: 11.83 (+0.76), CJES: 13.39 (-0.29), GE: 25.83 (-0.05), CLX: 105.46 (-0.62), DDD: 30.54 (-0.64), KMB: 117.77 (-0.21), RRD: 16.84 (+0.07), BMY: 59.15 (-0.01), KS: 29.97 (+0.03), HPQ: 40.54 (+0.18), CELG: 109.60 (+3.48), HAIN: 117.25 (+0.23), NLY: 11.21 (-0.05), CVS: 97.89 (+0.02), ABBV: 66.21 (+1.86), AGIO: 109.67 (+2.45), SNY: 46.35 (+0.50), REGN: 400.12 (+6.07)

2 Reasons On Why European Stocks Have Room To Grow
David Hunkar - Seeking Alpha - Wed Dec 17, 10:51AM CST
European stocks have been laggards this years relative to the decent performance of U.S. stocks. However moving forward, European stocks have better growth potential compared to their American peers for a variety of reasons two of which are discussed...
E: 36.10 (-0.25), SAN: 8.72 (+0.05), TEF: 14.81 (-0.02), SNY: 46.35 (+0.50)

3 Companies Growing Faster Than MannKind Corporation
Sean Williams, The Motley Fool - Motley Fool - Wed Dec 17, 6:03AM CST
Source: MannKind. MannKind shareholders have had quite the year. After more than doubling in the first half of the year, shares have since given back all of their gains and sit essentially unchanged. Despite the stalemate, MannKind could be on...
AKRX: 36.47 (+0.43), ALXN: 181.96 (+3.09), ACOR: 39.14 (+0.74), SNY: 46.35 (+0.50), MNKD: 5.68 (+0.18)

SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Sanofi To Contact Brower Piven Before The February 2, 2015 Lead Plaintiff Deadline In Class Action Lawsuit
Business Wire - Tue Dec 16, 3:31PM CST
The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of purchasers of Sanofi ("Sanofi" or the "Company" (NYSE: SNY) securities during the period between February 7, 2013 and December 3, 2014, inclusive (the "Class Period" . Investors who wish to become proactively involved in the litigation have until February 2, 2015 to seek appointment as lead plaintiff.
SNY: 46.35 (+0.50)

Alnylam Provides Pipeline Update, Growth Strategy - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Dec 15, 4:50PM CST
Alnylam (ALNY) announced a strategy for developing its RNAi therapeutics in three strategic therapeutic areas (STArs): genetic medicines, cardio-metabolic disease and hepatic infectious disease.
ALNY: 93.52 (+0.97), MDCO: 27.06 (+0.21), AMGN: 160.67 (+3.15), SNY: 46.35 (+0.50)

3 Healthcare Stocks to Watch in 2015
Sean Williams, The Motley Fool - Motley Fool - Mon Dec 15, 8:41AM CST
Source: Sanofi. The end of the year brings with it yuletide cheer, gatherings with friends and families, and perhaps even the swapping of holiday gifts. For healthcare investors, the end of the year also brings with it time to reflect on the year...
GILD: 91.29 (+1.84), ABBV: 66.21 (+1.86), SNY: 46.35 (+0.50), MNKD: 5.68 (+0.18), EXEL: 1.29 (-0.01)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Payoneer Gets OCC Nod, but the Finish Line Is Ahead

Updated Category News Views 121

Federal bank paperwork is not usually thrilling, yet Payoneer just found a potentially meaningful lever for its cross-border payments machine. The company received preliminary conditional approval from the Office of the Comptroller of the Currency to form PAYO Digital Bank, a national trust bank intended to support stablecoin services. That is a real regulatory milestone...

Continue Reading
North Richland Hills Bets on Its Visitor Momentum Now

Updated Category News Views 65

A crowded family attraction map is a nice problem for a Texas city to have, and North Richland Hills is trying to turn that pile of assets into a cleaner regional tourism machine. On Nov. 20, 2026, the city introduced “The Place You Never Outgrow,” its first destination-marketing campaign, built with Flat Five Marketing. This is not a stock story in the usual...

Continue Reading
Tigerlily Brings HIV Information to Women’s Health

Updated Category News Views 99

A stubborn information gap is exactly where Tigerlily Foundation is planting its flag. The nonprofit’s new national HIV education and awareness campaign, THE POWER OF U, expands work that began in breast cancer advocacy into another area where women need clear facts, trusted voices, and room to speak without being shamed for needing answers. This is not a story that...

Continue Reading
Jalisco’s Culinary Push Puts Tourism Strategy in Focus

Updated Category News Views 50

A destination sells itself twice: first with a memorable meal, then with a reason to come back. Jalisco’s stated effort to connect the world’s cuisines through The 50 Best Gastronomic Experiences belongs in that second category. It is not merely restaurant chatter. It reads as part of a broader attempt to make the state’s tourism offering feel deeper, more varied...

Continue Reading
Protein Now! Gains Clinician Attention, With Caveats

Updated Category News Views 91

A Small Bottle Has Drawn a Crowd Protein powder tubs have been cluttering kitchens for years; a 3.38-fluid-ounce shot is a cleaner answer to the same daily hassle. NutraBio Labs says more than 800 physicians, nurse practitioners, and physician associates had added PROTEIN NOW! to their individual FrontrowMD patient pages as of November 2026. That earned the product a...

Continue Reading
Fraud0-FouAnalytics Takes Aim at Legacy Ad Verification

Updated Category News Views 95

Digital ad measurement has spent years grading its own homework, and that little arrangement may finally be getting some daylight. fraud0 and FouAnalytics say their expanded partnership will give advertisers impression-level visibility into where ads actually rendered, whether apparent humans engaged with them, and where wasted Google Ads spend might be recoverable. The...

Continue Reading
Rock Gate Buys Aviation Niche Player Blast Deflectors

Updated Category News Views 167

Jet exhaust is not glamorous, but somebody has to keep it from battering everything nearby. Rock Gate Partners’ acquisition of Blast Deflectors, Inc. puts money behind one of those stubbornly unsexy industrial niches where engineering credibility matters far more than a flashy sales pitch. The transaction closed October 16, 2026, and Northborne Partners announced...

Continue Reading
Kinross Lawsuit Puts Round Mountain Claims Under Fire

Updated Category News Views 85

A mine can swallow a rosy forecast faster than any spreadsheet admits. That is the ugly center of the proposed securities class action involving Kinross Gold: not merely that production guidance came down, but the allegation that investors were sold too much confidence before the operational reality at Round Mountain Phase S surfaced. NYSE:KGC dropped from $27.62 on...

Continue Reading
Oatly’s $4.13 Tender Offer Is a Legal Detour, Not a Sale

Updated Category News Views 122

A $4.13 cash offer trading against a $7.17 close is the sort of thing that makes investors squint hard, and Verlinvest is practically waving a flag telling them why. This is not a conventional attempt to buy Oatly Group AB. It is a technical tender offer built to satisfy Swedish takeover rules while Verlinvest buys out its joint-venture partner’s interest in Oatly’s...

Continue Reading
DISA Backs Nursing Education With OADN Foundation Push

Updated Category News Views 79

A nursing workforce does not appear by magic when hospitals need it most; somebody has to help students, instructors, and programs survive the long haul before that first shift. DISA's newly announced partnership with the Organization for Associate Degree Nursing and the OADN Foundation is aimed squarely at that unglamorous, essential stretch of the pipeline. For a sector...

Continue Reading

Top 5 Most Recently Viewed Articles

Molina Healthcare: A Journey of 20 Years of Returns

Updated Category News Views 197

Molina Healthcare's Impressive Investment Journey Molina Healthcare (NASDAQ: MOH) has consistently outperformed the broader market over the last two decades, achieving an impressive annualized return of 12.15%. As a result, this sector leader has garnered significant attention from investors and analysts alike, showcasing its robust performance in the healthcare industry....

Continue Reading
Nokia's Strategic Buyback Program to Enhance Shareholder Value

Updated Category News Views 232

Nokia's Strategic Share Repurchase Initiative Nokia Corporation (NYSE:NOK) has embarked on a significant share repurchase program aimed at mitigating the dilution effects from recent share issuances. This initiative aligns with the company's ongoing commitment to enhancing shareholder value. Recently, Nokia executed the acquisition of 872,093 shares at an average price of...

Continue Reading
Justin Boots Unveils Stylish New Baby Boot Line for First Steps

Updated Category News Views 185

Introducing Mutton Busters Baby Boots by Justin Boots Justin Boots, a name that captures the essence of Western craftsmanship, has launched an exciting new collection for the tiny trendsetters: Mutton Busters. These infant boots are tailored specifically for babies, ensuring comfort, support, and a stylish touch as they take their first steps into the world. Features...

Continue Reading
Waterdrop Inc. Reports Significant Q3 Growth and Innovation

Updated Category News Views 203

Waterdrop Inc. Reports Impressive Financial Results for Q3 Waterdrop Inc. (NYSE: WDH), a prominent technology platform specializing in insurance and healthcare services, recently announced notable financial outcomes for the quarter that ended on September 30, 2025. This report highlights a commendable net operating revenue of RMB 974.9 million, marking a significant...

Continue Reading
Next Technology Holding Inc. Reports Remarkable H1 2025 Growth

Updated Category News Views 150

Next Technology Holding Inc. Delivers Impressive Financial Results for H1 2025 Next Technology Holding Inc. (NASDAQ: NXTT), a leading technology company focused on AI and Bitcoin investments, has released its financial results, showcasing a remarkable surge in performance for the first half of the year. The company, known for its commitment to creating innovative AI...

Continue Reading